🇺🇸 SECBiogen Inc.Codex · 实盘不做把握 5/10
北京时间·🕒 发布 18:10:24时区推断·待核·⟳ 抓取 10:24:24·⚡ 决策 07-29 18:13:31 +7h49m·90.1 天前
Biogen披露二季度业绩好于预期并上调全年指引
Biogen二季度调整后EPS约3.60美元，高于市场预期，并将全年调整后EPS指引上调至15.85-16.85美元。
📄 原文Biogen Inc.↗ 原文
Directory List of /Archives/edgar/data/875045/000087504526000073 Search Options Skip to Main Content About What We Do C…
不做 Biogen（BIIB.US）
二季度业绩和指引方向偏正面，但这是已排期盘前财报，Leqembi低于预期且电话会前增长质量仍待确认；当前不在无承接信息下开盘追多。
不做 Eisai（4523.JP）
Eisai只通过Leqembi合作间接受影响，而本次可见信息显示Leqembi低于预期，不构成清晰可执行的同向多头。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司提前公告将在2026-07-29美股开盘前披露二季度业绩，说明财报日历本身非突发。
- Biogen 8-K目录显示二季度业绩新闻稿作为Exhibit 99.1提交，接受时间为06:10 ET。
- 财经媒体报道Biogen二季度EPS和收入超预期，并上调全年盈利与收入增长指引。
关键理由
- Biogen二季度调整后EPS约3.60美元，高于市场预期，并将全年调整后EPS指引上调至15.85-16.85美元。
- 收入约27亿美元、同比增长约3%，增长组合收入超过传统MS业务，说明转型叙事有基本面支撑。
- 但这是已排期的盘前财报事件，核心交易还取决于开盘缺口和8:30 ET电话会对Leqembi与全年增长质量的解释。
主要风险
- Leqembi收入虽增长但低于预期，阿尔茨海默病管线近期数据也引发疑问，可能削弱业绩 beat 的持续重估。
- 财报日追多易受开盘跳空和电话会细节影响，若高开后资金兑现，短线风险收益不稳。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-07-29 · 影响 weakens
反向点是Leqembi收入低于预期，且阿尔茨海默病相关数据仍有争议，削弱单纯追财报beat的确定性。
检索:Biogen Q2 2026 Leqembi expectations earnings risk 原文 ↗
原文全文
展开原文 · 1,684 字
Directory List of /Archives/edgar/data/875045/000087504526000073
Search Options
Skip to Main Content
About
What We Do
Commissioners
Securities Laws
Reports
Careers
Contact
Divisions
Corporation Finance
Enforcement
Investment Management
Risk, Strategy and Innovation
Trading and Markets
National Exam Program
All Divisions and Offices
Litigation Releases
Administrative Proceedings
Opinions and Adjudicatory Orders
Accounting and Auditing
Trading Suspensions
How Investigations Work
Administrative Law Judges
Regulation
Proposed Rules
Final Rules
Interim Final Temporary Rules
Other Orders and Notices
Self-Regulatory Organizations
Staff Interpretations
Education
Investor.gov
Check Out a Broker or Adviser
Investor Alerts and Bulletins
Fast Answers
File a Tip or Complaint
Publications
Filings
Quick EDGAR Tutorial
Company Filings Search
Descriptions of SEC Forms
Requesting Public Documents
News
Press Releases
What's New
Upcoming Events
News Digest
Webcasts
Special Studies
Speeches and Public Statements
Testimony
Directory Listing /Archives/edgar/data/875045/000087504526000073
Parent Directory
Name
Size
Last Modified
0000875045-26-000073-index-headers.html
2026-07-29 06:10:24
0000875045-26-000073-index.html
0000875045-26-000073.txt
0000875045-26-000073-xbrl.zip
40030
biib-20260729.htm
24128
biib-20260729.xsd
1804
biib-20260729_htm.xml
2692
biib-20260729_lab.xml
21885
biib-20260729_pre.xml
12526
exhibit991-q22026pressrele.htm
599142
FilingSummary.xml
1638
MetaLinks.json
17095
newbiogenlogoa.jpg
2811
R1.htm
38050
report.css
2766
Show.js
1085
Site Map
Accessibility
Contracts
Privacy
Inspector General
FOIA
No FEAR Act & EEO Data
Open Government
Plain Writing
Links
USA.gov
Search Options
Skip to Main Content
About
What We Do
Commissioners
Securities Laws
Reports
Careers
Contact
Divisions
Corporation Finance
Enforcement
Investment Management
Risk, Strategy and Innovation
Trading and Markets
National Exam Program
All Divisions and Offices
Litigation Releases
Administrative Proceedings
Opinions and Adjudicatory Orders
Accounting and Auditing
Trading Suspensions
How Investigations Work
Administrative Law Judges
Regulation
Proposed Rules
Final Rules
Interim Final Temporary Rules
Other Orders and Notices
Self-Regulatory Organizations
Staff Interpretations
Education
Investor.gov
Check Out a Broker or Adviser
Investor Alerts and Bulletins
Fast Answers
File a Tip or Complaint
Publications
Filings
Quick EDGAR Tutorial
Company Filings Search
Descriptions of SEC Forms
Requesting Public Documents
News
Press Releases
What's New
Upcoming Events
News Digest
Webcasts
Special Studies
Speeches and Public Statements
Testimony
Directory Listing /Archives/edgar/data/875045/000087504526000073
Parent Directory
Name
Size
Last Modified
0000875045-26-000073-index-headers.html
2026-07-29 06:10:24
0000875045-26-000073-index.html
0000875045-26-000073.txt
0000875045-26-000073-xbrl.zip
40030
biib-20260729.htm
24128
biib-20260729.xsd
1804
biib-20260729_htm.xml
2692
biib-20260729_lab.xml
21885
biib-20260729_pre.xml
12526
exhibit991-q22026pressrele.htm
599142
FilingSummary.xml
1638
MetaLinks.json
17095
newbiogenlogoa.jpg
2811
R1.htm
38050
report.css
2766
Show.js
1085
Site Map
Accessibility
Contracts
Privacy
Inspector General
FOIA
No FEAR Act & EEO Data
Open Government
Plain Writing
Links
USA.gov
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。